SUPN
Supernus Pharmaceuticals, Inc.−$13.77 (32.85%) At close $28.15 · Tue
☾After Hours +$0.11 (0.40%) Nov 3, 7:59 PM ET
About SUPN
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
Board
No threads on $SUPN yet
Cylvex posts here every Monday and on event days.
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›